Prophylactic efficacy of a Basidiomycetes preparation AHCC against lethal Candida albicans infection in experimental granulocytopenic mice

Japanese Journal of Medical Mycology

Volumn 44, Issue 2, 2003, Pages 127-131

  Ikeda, Tatsuo ^a   Ishibashi, Hiroko ^a,b   Fujisaki, Ryuichi ^a,b   Yamazaki, Masatoshi ^b   Wakame, Kohji ^c   Kosuna, Kenichi ^c   Yamaguchi, Hideyo ^a,b   Ono, Yasuo ^a   Abe, Shigeru ^a,b  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c Amino Up Chemical Co   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE HEXOSE CORRELATED COMPOUND; ANTIFUNGAL AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; PREDNISOLONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASIDIOMYCETES; BLOOD; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FUNGUS GROWTH; GRANULOCYTOPENIA; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; MOUSE; NEUTROPHIL; NONHUMAN; OPPORTUNISTIC INFECTION; PROPHYLAXIS; SURVIVAL;

ANIMALIA; BASIDIOMYCOTA; CANDIDA ALBICANS; FUNGI;

EID: 0038246465     PISSN: 09164804     EISSN: None     Source Type: Journal    
DOI: 10.3314/jjmm.44.127     Document Type: Article

References (15)

1. Brakhage AA, Jahn B, Schmidt A: Aspergillus fumigatus. Biology, Clinical Aspects and Molecular Approaches to Pathogenicity. Contrib Microbiol Basel, Karger, Vol. 2, 1999.
2. Odds FC: Candida and Candidosis. A review and Bibliography. Bailliere Tindall, London Philadelphia Toronto, Sydney Tokyo 1988.
3. Abe S, Tansho S, Ishibashi H, Akagawa G, Komatsu Y, Yamaguchi H: Protection of immunosuppressed mice from lethal Candida infection by oral administration of a kampo medicine, Hochu-ekki-to. Immunopharm Immunotoxicol 21(2): 331-342, 1999.
4. Abe S, Tansho S, Ishibashi H, Inagaki N, Komatsu Y, Yamaguchi H: Protective effect of oral administration of a traditional medicine, Juzen-taiho-to, and its components on lethal Candida albicans infection in immunosuppressed mice. Immunopharm Immunotoxicol 20: 421-431, 1998.
5. Akagawa G, Abe S, Tansho S, Yamaguchi H: Protection of C3H/HeJ mice from development of Candida albicans infection by oral administrati on of Juzen-taihoto and its component, ginseng radix: possible roles of macrophage in the host defense mechanisms. Immunopharm Immunotoxicol 18: 73-89, 1996.
6. Matsushita K, Kuramitsu Y, Ohiro Y, Obara M, Kobayashi M, Li Y-Q, Hosokawa M: Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anti-Cancer Drugs 9: 343-350, 1998.
7. YAKUGAKU ZASSHI 120(8): 715-719, 2000
8. Gilmore GL, Depasquale DK, Shadduck RK: Protective effects of BB-10010 treatment on chemotherapy induced neutropenia in mice. Exp Hematol 27(2): 195-202, 1999.
9. Lynch DH, Rubin AS, Miller RE, Williams DE: Protective effects of recombinant human interleukin-1 alpha in doxorubicin-treated normal and tumor-bearing mice. Cancer Res 53(7): 1565-70, 1993.
10. Uchida K, Yamaguchi H, Shibuya K: The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections. Jpn J Antibiot 44: 588-599, 1991
11. Ikeda T, Suegara N, Abe S, Yamaguchi H: Efficacy of antibacterial drugs in mice with complex infection by Candida albicans and Escherichia coli. J Antibiotics 52(6): 552-558, 1999.